New Delhi: The World Health Organization (WHO) is likely to take a decision on including Bharat Biotech’s anti-Covid-19 vaccine Covaxin in the Emergency Use List (EUL) in four to six weeks. WHO Chief Scientist Soumya Viswanathan said this. Addressing a webinar organized by the Center for Science and Environment (CSE) on Friday, Swaminathan said that Bharat Biotech, the manufacturer of the vaccine, is uploading all its data on our portal and WHO is reviewing this vaccine. According to WHO guidelines, EUL is a process by which new or unlicensed products can be used in public health emergencies.
Swaminathan said, “EUL has a process in which a company has to complete Phase III trials and submit all the data to the regulatory department of WHO which is studied by an expert advisory group.” “Full statistics are provided including safety and effectiveness and production quality standards. Bharat Biotech has already submitted the data and I am hopeful that in four to six weeks a decision will be taken on the inclusion of the vaccine.
